Dr. David Larson Demill, MD

Dr. Demill practices at Salt Lake Clinic - Mammography in Salt Lake City, Utah.

Dr. Demill's NPI, 1366783631, was assigned on March 11, 2013. Dr. Demill graduated from Spencer Fox Eccles School of Medicine in 2012. Dr. Demill's North Dakota license number on file is 15521.

Dr. Demill's primary practice is Salt Lake Clinic - Mammography, at 389 S. 900 E., Salt Lake City, UT 84102. The practice phone is (833) 626-4666.

Dr. Demill's primary practice is Salt Lake Clinic - Mammography in Salt Lake City, Utah. Dr. Demill is also affiliated with St. Mark's Hospital. The medical group on file is Intermountain Health. Dmand AI also links Dr. Demill to 1 more hospital, 1 breast imaging center, 1 group practice or clinic, 1 ambulatory surgery center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Demill practices, 6 sites in all. Vendor and product names are available with a free account.

Cornea and external diseases specialist is Dr. Demill's primary specialty in the NPI Registry, under taxonomy code 207WX0120X. Dr. Demill is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Demill's licenses on file in 5 states: North Dakota, Utah, Indiana, Oregon and Michigan.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eyelid inflammation and glaucoma among the conditions Dr. Demill treats.

CMS data shows 1,498 Medicare services from Dr. Demill across 12 procedure codes in 2024, for 629 Medicare patients. Medicare paid $169,261 for them.

CMS counts 629 Medicare patients who saw Dr. Demill in 2024. The largest group is 65 to 74, with 311 patients. 68% of them have high cholesterol, and 65% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.07, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Demill's median patient age at 72, with 56% women.

In 2024, Dr. Demill wrote 3,017 Medicare Part D claims for 698 patients. 54% of them were for generic drugs. CMS names the drug for 2,915 of them, across 21 drugs with 11 or more claims each, at $200,384 in total drug cost. In 2023, CMS named 2,657 claims across 22 drugs.

Dr. Demill accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 434 procedures of cataract surgery by Dr. Demill, more than 94% of the clinicians it reports for that procedure.

Dmand AI links 10 papers to Dr. Demill, published from 2011 to 2015. 2011 was the busiest year, with 2. The most frequent topics are Antihypertensive Agents, Intraocular Pressure and Cell Count. Dr. Demill has published most often in Clin Ophthalmol. Dr. Demill's most frequent co-authors are Lindsay Nelson, DO, Barbara M. Wirostko, MD and Maylon Hsu, MD.

CMS Open Payments shows 37 general payments to Dr. Demill from 15 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 98% of the total. Johnson & Johnson Surgical Vision, Inc. paid the most, $469.

Dmand AI lists 4 awards for Dr. Demill, most recently Alpha Omega Alpha in 2012.

Dr. Demill graduated from Spencer Fox Eccles School of Medicine in 2012. Dr. Demill is a member of AOA and AAO.

Dr. Demill is in network with 16 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.